ATE358477T1 - Oral anzuwendende arzneizusammensetzung enthaltend ein statinderivat - Google Patents
Oral anzuwendende arzneizusammensetzung enthaltend ein statinderivatInfo
- Publication number
- ATE358477T1 ATE358477T1 AT02727063T AT02727063T ATE358477T1 AT E358477 T1 ATE358477 T1 AT E358477T1 AT 02727063 T AT02727063 T AT 02727063T AT 02727063 T AT02727063 T AT 02727063T AT E358477 T1 ATE358477 T1 AT E358477T1
- Authority
- AT
- Austria
- Prior art keywords
- composition containing
- medicinal composition
- statin derivative
- oral medicinal
- oral
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BE200100098 | 2001-06-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE358477T1 true ATE358477T1 (de) | 2007-04-15 |
Family
ID=31501421
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02727063T ATE358477T1 (de) | 2001-06-12 | 2002-06-11 | Oral anzuwendende arzneizusammensetzung enthaltend ein statinderivat |
Country Status (6)
Country | Link |
---|---|
US (1) | US20040235935A1 (de) |
EP (1) | EP1395254B1 (de) |
AT (1) | ATE358477T1 (de) |
CA (1) | CA2450238A1 (de) |
DE (1) | DE60219307T2 (de) |
WO (1) | WO2002100394A1 (de) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1581210B1 (de) * | 2002-12-20 | 2008-03-19 | Pfizer Products Inc. | Dosierungsform enthaltend einen cetp-hemmer und einen hmg-coa reduktase hemmer |
ATE407670T1 (de) * | 2002-12-20 | 2008-09-15 | Pfizer Prod Inc | Dosierungsform enthaltend einen cetp-hemmer und einen hmg-coa reduktase hemmer |
US20090042979A1 (en) * | 2004-08-06 | 2009-02-12 | Transform Pharmaceuticals Inc. | Novel Statin Pharmaceutical Compositions and Related Methods of Treatment |
JP2008516890A (ja) * | 2004-08-06 | 2008-05-22 | トランスフオーム・フアーマシユーチカルズ・インコーポレーテツド | 新規なフェノフィブラート製剤および関連治療方法 |
WO2006017698A2 (en) | 2004-08-06 | 2006-02-16 | Transform Pharmaceuticals, Inc. | Novel statin pharmaceutical compositions and related methods of treatment |
BRPI0513939A (pt) * | 2004-08-23 | 2008-05-20 | Unilever Nv | composição, formador de creme e/ou clareador, composição de alimento, processo para a manufatura de uma composição e uso de uma composição |
ES2255426B1 (es) | 2004-10-19 | 2007-08-16 | Gp Pharm, S.A. | Formulacion farmaceutica que comprende microcapsulas de estatinas suspendidas en ester alquilicos de acidos grasos poliinsaturados (pufa). |
EP1818050A1 (de) * | 2006-02-10 | 2007-08-15 | Stada Arzneimittel Ag | Stabile pharmazeutische Zusammensetzungen umfassend einen HMG-CoA-Reduktase Inhibitor |
EP1825848A3 (de) * | 2006-02-10 | 2010-03-03 | Stada Arzneimittel Ag | Stabile pharmazeutische Zusammensetzungen umfassend einen HMG-CoA-Reduktase Inhibitor |
WO2007103557A2 (en) | 2006-03-09 | 2007-09-13 | Reliant Pharmaceuticals, Inc. | Coating capsules with active pharmaceutical ingredients |
ES2385752T3 (es) * | 2006-04-26 | 2012-07-31 | Rosemont Pharmaceuticals Ltd | Composiciones orales líquidas |
EP2220208A4 (de) * | 2007-11-23 | 2010-12-29 | Rappaport Family Inst For Res | Verwendung von haptoglobingenotypisierung zur diagnose und behandlung von herz-kreislauf-erkrankungen |
ITFI20080243A1 (it) * | 2008-12-15 | 2010-06-16 | Valpharma Sa | Formulazioni per la somministrazione orale di acidi grassi omega polienoici in combinazione con statine di origine naturale o semi-sintetica. |
CA2706270C (en) * | 2010-06-03 | 2020-01-07 | Accucaps Industries Limited | Pharmaceutical formulations of statins and omega-3 fatty acids for encapsulation |
US8937081B2 (en) | 2011-12-12 | 2015-01-20 | PruGen IP Holdings, Inc. | Statin bioavailability enhancement delivery composition |
EP2983711A4 (de) | 2013-04-08 | 2016-11-23 | Cytodyn Inc | Felinisierte antikörper und verfahren zur behandlung von retrovireninfektionen bei katzen |
WO2015185240A1 (en) | 2014-06-04 | 2015-12-10 | Sigma-Tau Industrire Farmaceutiche Riunite S.P.A. | Compositions containing simvastatin in omega-3 polyunsaturated fatty acids |
EP3468606A1 (de) | 2016-06-08 | 2019-04-17 | FTF Pharma Private Limited | Neuartige pharmazeutische zusammensetzung aus einer lipidsenkenden verbindung |
GB201704687D0 (en) | 2017-03-24 | 2017-05-10 | Wockhardt Uk Ltd | Pharmaceutical composition of simvastatin or salt thereof |
WO2022129002A1 (en) * | 2020-12-15 | 2022-06-23 | Dsm Ip Assets B.V. | Coarse dispersion comprising statin and vitamin e oil |
WO2022129004A1 (en) | 2020-12-15 | 2022-06-23 | Dsm Ip Assets B.V. | Coated statin tablet comprising vitamin e acetate powder |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9405304D0 (en) * | 1994-03-16 | 1994-04-27 | Scherer Ltd R P | Delivery systems for hydrophobic drugs |
EP1049459B1 (de) * | 1998-01-20 | 2009-04-22 | Applied Analytical Industries, Inc. | Orale flüssige zusammensetzungen |
AU1323400A (en) * | 1998-10-27 | 2000-05-15 | Fuisz Technologies Ltd. | Microparticles containing peg and/or peg glyceryl esters |
EP1133308B1 (de) * | 1998-11-25 | 2003-11-12 | Nutri Pharma ASA | Zusammensetzung enthaltend sojaprotein, diätfasern und phytoestrogen sowie ihre verwendung zur vorbeugung und/oder behandlung von kardiovaskulären erkrankungen |
CA2355820A1 (en) * | 1998-12-18 | 2000-06-29 | Abbott Laboratories | Novel formulations comprising lipid-regulating agents |
WO2000057859A1 (en) * | 1999-03-31 | 2000-10-05 | Abbott Laboratories | Novel formulations comprising lipid-regulating agents |
WO2000057918A2 (en) * | 1999-03-31 | 2000-10-05 | Abbott Laboratories | Novel formulations comprising lipid-regulating agents |
US6372251B2 (en) * | 1999-06-11 | 2002-04-16 | Abbott Laboratories | Formulations comprising lipid-regulating agents |
-
2002
- 2002-06-11 AT AT02727063T patent/ATE358477T1/de not_active IP Right Cessation
- 2002-06-11 CA CA002450238A patent/CA2450238A1/en not_active Abandoned
- 2002-06-11 EP EP02727063A patent/EP1395254B1/de not_active Expired - Lifetime
- 2002-06-11 US US10/480,131 patent/US20040235935A1/en not_active Abandoned
- 2002-06-11 DE DE60219307T patent/DE60219307T2/de not_active Expired - Fee Related
- 2002-06-11 WO PCT/BE2002/000095 patent/WO2002100394A1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
EP1395254B1 (de) | 2007-04-04 |
DE60219307T2 (de) | 2008-01-10 |
CA2450238A1 (en) | 2002-12-19 |
EP1395254A1 (de) | 2004-03-10 |
US20040235935A1 (en) | 2004-11-25 |
WO2002100394A1 (en) | 2002-12-19 |
DE60219307D1 (de) | 2007-05-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE358477T1 (de) | Oral anzuwendende arzneizusammensetzung enthaltend ein statinderivat | |
CL2009001682A1 (es) | Composición farmacéutica espontáneamente dispersable para administración oral que comprende n-benzoil-estaurosporina; método para incrementar los niveles de biodisponibilidad. (divisional de la solocitud 333-00). | |
ATE359077T1 (de) | Orale gabe von 6-hydroxy-oxymorphon als analgetikum | |
NO20033343L (no) | Farmasöytiske doseringsformer av epothiloner for oral administrasjon | |
EE200200357A (et) | Ravimaine suurenenud kontsentratsioone andvad farmatseutilised kompositsioonid | |
DE122011100049I1 (de) | Stabile pharmazeutische Losungsformulierungen fur unter Druck stehende Inhaliergerate fur die Verabreichung abgemessener Dosen. | |
CY1112333T1 (el) | Φαρμακευτικο παρασκευασμα που περιεχει μια δραστικη ουσια πανω σε μια μητρα | |
ATE235897T1 (de) | Arzneimittel in form parenenteral verabreichbarer lipidmikropartikel | |
DE60334773D1 (de) | Formulierungen zur oralen verabreichung von wirkstoffen | |
ATE292453T1 (de) | Antivirale arznei | |
FR2764889B1 (fr) | Nouveaux derives du 2-(iminomethyl)amino-phenyle, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant | |
DE60317803D1 (de) | Pharmazeutische zusammensetzungen enthaltend cyclosporin zur oralen verabreichung | |
BR0314898A (pt) | Compostos, composição cosmética, uso cosmético de uma composição, uso de um composto e composição farmacêutica | |
ATE367152T1 (de) | Herstellungsverfahren für niedrig dosierte pharmazeutische zusammensetzung | |
MY129450A (en) | Pharmaceutical composition | |
ATE131383T1 (de) | Arzneimittel | |
HUP0400115A2 (hu) | Gyógyászati készítmény fulvesztrant intramuszkuláris beadására | |
DK1225902T3 (da) | Ciclesonidholdigt farmaceutisk præparat til administration til slimhinden | |
ATE337016T1 (de) | Zusammensetzungen zur erhöhung der bioverfügbarkeit von oral verabreichten pharmazeutischen verbindungen | |
HUP0301082A2 (hu) | Új polimorf olanzapine hidroklorid sók, eljárás ezek előállítására, az ezeket tartalmazó gyógyászati készítmények és felhasználásuk | |
NO20024108L (no) | Oralt administrert kontrollert leveringssystem for en daglig administrering av ciprofloksasin | |
NO20043007L (no) | Farmasoytisk suspensjon for oral administrering | |
DE60007074D1 (de) | Sulfatierte phosphatidylinositole, ihre herstellung und verwendung | |
EA200602199A1 (ru) | Композиции, содержащие глюкозаминогликан и нестероидное противовоспалительное средство | |
FR2861992B1 (fr) | Composition pharmaceutique destinee a l'administration orale d'un derive de pyrazole-3-carboxamide. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |